New Skinvisible, Inc. (SKVI) Subsidiary Signs Exclusive License Agreement to Distribute Its Topical Cannabis Products in the USA
Ryan Allway
November 16th, 2017
News, Top News
Skinvisible Pharmaceuticals, Inc. (“Skinvisible”) (OTCQB: SKVI), a research and development company with a patented drug delivery system called Invisicare®, today announces the formation of its Ovation Science, Inc. subsidiary, and the company’s definitive license agreement with Lighthouse Strategies, LLC (“Lighthouse”). Per the agreement via Ovation, Lighthouse has exclusive use of Ovation’s patented topical and transdermal formulations for select USA markets.
Through the technology division of Lighthouse, and in participation with the Advocacy Research Center “ARC,” a San Diego-based research center, founded to further the research and development of treatments in the areas of; Parkinson’s, oncology, pain management, PTSD, sleep disorders and seizure management; Lighthouse will introduce Ovation’s topical and transdermal products formulated with its patented drug delivery system and in doing so drive the development of safe, healthy, lifestyle-integrated treatments with the added benefit of accurate time released dosing.
National distribution of products and brands will be conducted through Cannabiniers, an established technology and brand management company and subsidiary of Lighthouse. Cannabiniers is revolutionizing the cannabis industry with its patented technologies and will leverage its expertise in the local, regional and national cannabis markets to distribute treatments that incorporate Ovation’s topical products in the United States. Their flagship product Brewbudz® is already launched in Nevada with aggressive expansion plans slated for California, Colorado, Washington State, Oregon, and Arizona.
“We are excited to have Cannabiniers as a partner in the U.S. cannabis market. They are branding experts and have the vision and infrastructure to take Ovation’s cannabis products across the United States,” says Skinvisible President Terry Howlett. “Leveraging Cannabiniers branding strategies, we have the ability to enter these markets and provide consumers with an exceptional variety of topical and transdermal products backed by science and formulated with patented technology.”
“Our goal is to normalize consumption and use cannabis so that it integrates within the daily lives of patients and consumers. We have achieved that with our current brands and our goal is to do the same with the topical products from Ovation,” said Timothy Walters, President of Cannabiniers. “We are excited to be working with Ovation as we seek to provide patients and consumers with the best products made with patented technology, essentially game changers within the cannabis market.”
Skinvisible also announces the formation of its Canadian subsidiary Ovation Science Inc. Ovation Science was created to better serve the needs of its licensees and to focus on specific product development for the cannabis market. The subsidiary has been granted exclusive worldwide rights to all products formulated using Skinvisible’s patented Invisicare® technology with cannabis and hemp seed oil.
In September, Skinvisible signed a licensing agreement with Canopy Growth Corporation, the world’s largest cannabis company, for the exclusive rights for Canada and right of first refusal on other countries outside of Canada and the U.S. where cannabis is government approved. The Canopy license agreement has been assigned to Ovation.
About Cannabiniers
Cannabiniers, located in San Diego, California, is a foodservice, technology and brand management company focusing on products that are healthy for the consumer and that positively impact the environment. Cannabiniers is revolutionizing the cannabis industry with patented, safe and natural flower-based extraction technology and products that will continue to the mission of normalizing cannabis use.
About Skinvisible Pharmaceuticals, Inc. & Ovation Science Inc.
Skinvisible Pharmaceuticals is a research and development company that licenses its proprietary formulations made with Invisicare®, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, allowing for the controlled release of actives. Ovation Science Inc. is a Canadian subsidiary of Skinvisible and holds all rights to Skinvisible’s cannabis products. For more information, visit www.Skinvisible.com or www.Invisicare.com
About Lighthouse Strategies, LLC.
Lighthouse Strategies, located in San Diego, California, is a finance, research & technology, real estate, & portfolio management company, with in excess of 100,000 square feet of real estate under management, supporting national & international intellectual property management, and maintaining ten (10) subsidiaries, ranging from foodservices, beverage services, breweries and distilleries (future). For more information, visit www.lighthousestrategies.co
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry.
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
